Country: Jerman
Bahasa: Inggeris
Sumber: HMA (Heads of Medicines Agencies)
toltrazuril 50 mg/ml
CEVA Santé Animale
QP51AJ01
Oral suspension
toltrazuril
Pigs Young
2012-02-13
1/4 Dokument1 Jan. 09 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT CEVAZURIL 50 mg/ml, oral suspension for piglets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Toltrazuril ........................... 50.0 mg EXCIPIENTS: Sodium benzoate (E211)......... 2.1 mg Sodium propionate (E281) ...... 2.1 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral suspension. White homogeneous suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Piglets. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the prevention of clinical signs of coccidiosis in neonatal piglets on farms with a confirmed history of coccidiosis caused by Isospora suis. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES It is recommended to treat all piglets in a litter. Hygienic measures may reduce the risk of porcine coccidiosis. It is therefore, recommended to improve concomitantly the hygienic conditions in the concerned facility, particularly dryness and cleanliness. To alter the course of an established clinical coccidial infection, in individual animals already showing signs of diarrhoea, additional supportive therapy may be required. As with any antiparasiticide, frequent and repeated use of antiprotozoals from the same class may lead to the development of resistance. 2/4 Dokument1 Jan. 09 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS None known. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Baca dokumen lengkap